Showing results (2851-2860 of 3,298) with videos related to

Sort By:
Pageof 330
International Journal of Environmental Research and Public Health|April 12, 2022
Predictors of eHealth Literacy and Its Associations with Preventive Behaviors, Fear of COVID-19, Anxiety, and Depression among Undergraduate Nursing Students: A Cross-Sectional SurveyHa T T Tran, Minh H Nguyen, Thu T M Pham, et al.
Nature Communications|May 10, 2025
Let-7 restrains an epigenetic circuit in AT2 cells to prevent fibrogenic intermediates in pulmonary fibrosisMatthew J Seasock, Md Shafiquzzaman, Maria E Ruiz-Echartea, et al.
Urologic Oncology|March 20, 2018
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapyLuke C Peng, Amol K Narang, Carol Gergis, et al.
Hepatology (Baltimore, Md.)|April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionNancy Reau, Paul Y Kwo, Susan Rhee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalisAyesha Khan, Milya Davlieva, Diana Panesso, et al.
American Journal of Human Genetics|March 27, 2018
Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating LeukodystrophyMarisa I Mendes, Mariana Gutierrez Salazar, Kether Guerrero, et al.
Scientific Reports|July 9, 2024
Severity predictors for multisystemic inflammatory syndrome in children after SARS-CoV-2 infection in VietnamDien M Tran, Dem V Pham, Tung V Cao, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Let-7 restrains an oncogenic circuit in AT2 cells to prevent fibrogenic cell intermediates in pulmonary fibrosisMatthew J Seasock, Md Shafiquzzaman, Maria E Ruiz-Echartea, et al.
JCO Precision Oncology|August 11, 2021
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic ProfilingHai T Tran, Vincent K Lam, Yasir Y Elamin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib TreatmentRunzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Pageof 330